Liothyronine (T3) Overview, Dosing & Safety | Peptide Database

Liothyronine (T3) (T3)

Thyroid Hormone | Metabolic Optimization

Community Research

Join others researching Liothyronine (T3) — share findings, ask questions, and learn from real experiences

Liothyronine (T3) is the biologically active form of thyroid hormone, responsible for regulating basal metabolic rate, thermogenesis, protein synthesis, and cellular energy metabolism throughout the body. Unlike levothyroxine (T4), which serves primarily as a prohormone requiring peripheral conversion by deiodinase enzymes, T3 acts directly on nuclear thyroid hormone receptors to exert its metabolic effects. It has been FDA-approved since the 1950s for the treatment of hypothyroidism, myxedema coma, and as a diagnostic agent in thyroid suppression tests. Pharmaceutical T3 is available as Cytomel (brand) and generic liothyronine sodium tablets. In performance and biohacking contexts, T3 is widely used during cutting phases to accelerate fat loss by directly upregulating metabolic rate, and by individuals seeking metabolic optimization when peripheral T4-to-T3 conversion is impaired due to caloric restriction, stress, or other factors.

Liothyronine enters target cells via monocarboxylate transporter 8 (MCT8) and other thyroid hormone transporters, then binds to nuclear thyroid hormone receptors (primarily TR-beta in metabolic tissues and TR-alpha in cardiac tissue). The T3-receptor complex forms heterodimers with retinoid X receptors (RXR) and binds to thyroid hormone response elements (TREs) on DNA, directly modulating gene transcription. This increases expression of Na+/K+ ATPase (driving cellular energy expenditure), uncoupling proteins (UCP1 in brown adipose tissue, promoting thermogenesis), and enzymes involved in fatty acid oxidation, gluconeogenesis, and protein turnover. T3 also upregulates beta-adrenergic receptor density, which amplifies catecholamine sensitivity and contributes to increased heart rate, lipolysis, and thermogenesis. At physiological doses, T3 supports healthy metabolism; at supraphysiological doses, it shifts the body into a catabolic state where both fat and lean tissue can be catabolized for energy.

Molecular Data

Research Indications

Treatment of overt and subclinical hypothyroidism, either as monotherapy or in combination with levothyroxine (T4). Particularly useful in patients who report persistent symptoms despite normalized TSH on T4 monotherapy, suggesting poor peripheral conversion.

Emergency treatment of severe hypothyroidism presenting as myxedema coma. Intravenous T3 is preferred due to its rapid onset of action compared to T4.

Supplementation in individuals with documented poor conversion of T4 to T3 due to deiodinase polymorphisms (DIO2 gene variants), chronic caloric restriction, illness, or elevated reverse T3 levels.

Diagnostic use in thyroid suppression tests to differentiate between types of thyroid autonomy.

Widely used in bodybuilding and physique sports to accelerate fat loss during caloric deficit. T3 increases basal metabolic rate by 10-15% at moderate doses, promoting faster utilization of stored fat. Most effective when combined with adequate protein intake and resistance training to minimize muscle catabolism.

Used by biohackers and longevity-focused individuals to maintain optimal metabolic rate, particularly during extended caloric restriction, reverse dieting, or in the context of metabolic adaptation (adaptive thermogenesis).

Standard component of bodybuilding contest prep stacks, typically combined with anabolic steroids (to offset catabolism) and beta-2 agonists for maximal fat mobilization in the final 6-8 weeks before competition.

Dosing Protocols

Liothyronine is administered orally as tablets, which is the standard and essentially only route used outside of emergency clinical settings. Oral bioavailability is approximately 95%, making it highly effective by mouth. Tablets are available in 5 mcg, 25 mcg, and 50 mcg strengths. The short half-life (~24 hours) means that split dosing throughout the day can provide more stable blood levels, though once-daily dosing is common for replacement therapy.

Thyroid Replacement - Standard

25-75 mcg/day

Once daily or split into 2-3 doses

Oral

Thyroid Replacement - Conservative Start

5-25 mcg/day

Once daily

Fat Loss - Moderate

25-50 mcg/day

Split into 2 doses (AM and early PM)

Fat Loss - Aggressive (Contest Prep)

50-75 mcg/day

Split into 2-3 doses

T4/T3 Combination Therapy

5-15 mcg/day (added to T4)

Once daily or split into 2 doses

Interactions

What to Expect

Side Effects & Safety

Common Side Effects

Tachycardia and palpitations (increased heart rate, especially at higher doses)

Anxiety, nervousness, and irritability

Insomnia and disrupted sleep architecture

Increased sweating and heat intolerance

Tremor (fine hand tremor, similar to hyperthyroid presentation)

Increased appetite despite accelerated metabolism

Loose stools or increased bowel frequency

Stop Signs - Discontinue if:

Chest pain, pressure, or significant palpitations

Resting heart rate consistently above 100-110 bpm

Severe anxiety or panic attacks

Significant unexplained muscle weakness or wasting

Signs of adrenal crisis: severe fatigue, hypotension, nausea, dizziness

Irregular heartbeat or sensation of skipped beats

Contraindications

Untreated adrenal insufficiency (must correct cortisol deficiency before starting T3)

Acute myocardial infarction or unstable angina

Thyrotoxicosis or untreated hyperthyroidism

Known hypersensitivity to liothyronine or any tablet excipients

Uncorrected adrenal cortical insufficiency (risk of adrenal crisis)

Quality Checklist

Good Signs

Pharmaceutical-grade tablets from licensed manufacturer (Cytomel or reputable generic)

Proper labeling with strength (5, 25, or 50 mcg), lot number, and expiration date

Tablets are uniform in color, size, and shape with clean edges

Prescribed by licensed physician with documented thyroid lab work

Stored in original container at room temperature, protected from moisture and light

Warning Signs

Research chemical or compounded liquid T3 without third-party potency verification

Tablets that crumble easily or show discoloration (potential degradation)

Product sourced internationally without verification of manufacturer legitimacy

Bad Signs

No labeling, incorrect strength labeling, or missing expiration date

Tablets with inconsistent sizing or visible damage

Product sourced from unverified supplier with no testing documentation

Counterfeit packaging or misspelled brand names

Frequently Asked Questions

Is T3 safe to use without a testosterone base?

T3 alone is not ideal without exogenous testosterone during a fat-loss cycle because the compound is profoundly catabolic at higher doses (above 50 mcg/day). Without testosterone to preserve lean tissue, T3 will catabolize muscle alongside fat. A testosterone base of 100-200 mg/week is standard practice to mitigate lean mass loss—this converts it from a cutting compound to a true body recomposition tool.

Can I use T3 with levothyroxine (T4)?

Yes, T3/T4 combination therapy is common and often more effective than either alone. The typical ratio is 13:1 to 20:1 (T4:T3)—for example, 75 mcg T4 with 5-10 mcg T3. This mimics physiological thyroid output better than T4 alone and can improve symptoms in individuals with poor T4-to-T3 conversion or high reverse T3. Always taper T3 gradually at cycle end, not abruptly.

What's the maximum safe dose of T3 for fat loss?

Doses above 75 mcg/day significantly increase muscle wasting risk and cardiovascular stress without proportional fat-loss benefit. The sweet spot for performance contexts is 50-75 mcg/day split into 2-3 doses, always combined with adequate protein and a testosterone base. Never exceed 8 weeks at doses above 50 mcg without comprehensive monitoring and medical oversight.

Does T3 require tapering, or can I stop abruptly?

Always taper T3 gradually over 1-2 weeks; abrupt discontinuation can cause severe fatigue, depression, and metabolic crash as endogenous thyroid function rebounds. Taper by reducing 12.5 mcg every 2-3 days. This slow reduction also allows your natural thyroid axis to re-establish without the shock of sudden temperature and energy collapse.

References

Systematic review of T3 and T3/T4 combination therapy for hypothyroidism. Found that while T3 monotherapy normalizes thyroid markers, combination T4/T3 therapy may benefit a subset of patients with persistent symptoms on T4 alone, particularly those with DIO2 polymorphisms.

Comprehensive ATA guidelines addressing the use of liothyronine in hypothyroidism management. Recommends levothyroxine as first-line therapy but acknowledges a role for T3 combination therapy in patients who remain symptomatic, with careful monitoring of TSH and free T3 levels.

Detailed review of thyroid hormone mechanisms including T3-mediated regulation of basal metabolic rate, thermogenesis via uncoupling proteins, lipid metabolism, and mitochondrial biogenesis. Clarifies the distinct roles of TR-alpha and TR-beta receptor isoforms in different tissues.

Demonstrated that patients carrying the DIO2 Thr92Ala polymorphism showed improved well-being and preference for combination T4/T3 therapy over T4 monotherapy, providing a genetic basis for individual variation in response to thyroid hormone replacement strategies.

Review of T3's role in body composition regulation, including its effects on resting energy expenditure, lipid oxidation, and the metabolic consequences of both hypothyroid and hyperthyroid states. Highlights the dose-dependent shift from anabolic to catabolic effects.

Related Peptides

Commonly stacked during cutting phases. Testosterone helps preserve lean muscle mass that T3 would otherwise catabolize at higher doses. The combination allows for more aggressive T3 dosing with reduced risk of muscle wasting. No direct pharmacological conflict.

Disclaimer

This information is for educational and research purposes only. Consult a healthcare professional before use.